-
Disemba 3, 2024, umuthi omusha i-Zepzelca (i-lurbinectin yomjovo) uvunyelwe ukumakethwa yi-National Medical Products Administration (NMPA) yaseShayina ngohlelo lokubuyekeza okubalulekile. Umuthi ukhonjiswe ekwelapheni iziguli ezindala ezine-metastatic small cell lung caries...Funda kabanzi»
-
Ngomhlaka-31 Disemba, i-National Medical Products Administration (NMPA) yaseShayina ivumile i-VYLOYTM (zolbetuximab), ngokuhlanganiswa ne-fluoropyrimidine kanye ne-platinum-containing chemotherapy, yokwelashwa kokuqala kweziguli ezine-human epidermal growth ethuthukisiwe endaweni noma esakazekile...Funda kabanzi»
-
Disemba 31, 2024, iSichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("iNkampani") ithole imvume yokumaketha eShayina evela ku-National Medical Products Administration (NMPA) ye-programmed cell death ligand1(PD-L1)-directed humanized monoclonal antibody (“mAb”) tagitanlim...Funda kabanzi»
-
I-C-CAR031 iyindlela yokwelapha ye-T-T (CAR-T) eqondiswe yi-GPC3, ehlonyiswe nge-autologous, ehlonyiswe yi-chimeric antigen receptor T-Cell (CAR-T), efundelwa ukwelashwa kwe-HCC. Isekelwe ku-CAR-T entsha eqondiswe yi-GPC3 eklanywe yi-AstraZeneca isebenzisa i-dominant negative transforming growth factor-beta receptor II dominant negati...Funda kabanzi»
-
Disemba 20, 2024, I-National Medical Products Administration (NMPA) yaseShayina ivumile i-New Drug Application (NDA) ye-DOVBLERON ® (taletrectinib adipate capsule), i-ROS1 tyrosine kinase inhibitor (TKI) yesizukulwane esilandelayo, yokwelapha iziguli ezindala ezine-ROS ethuthukisiwe noma esakazeke endaweni...Funda kabanzi»
-
I-C-CAR031 iyindlela yokwelapha i-T-Cell (CAR-T) eqondiswe yi-GPC3, ehlolwa ngokwelashwa kwe-HCC. Inqubekela phambili yocwaningo lwe-C-CAR031 ku-carcinoma ye-hepatocellular (HCC) yethulwe ngomlomo emhlanganweni waminyaka yonke we-American Society of Clinical Oncology (ASCO) ...Funda kabanzi»
-
I-GT101 iyindlela yokwelapha ngamaseli e-autologous eyenziwe nge-TIL enwetshiwe futhi evuselelwe kusuka ku-tumor yesiguli. Ukwelashwa kuphathwa ngokuqoqwa kwezicubu ze-tumor ezigulini bese kukhishwa i-TIL. I-TIL ekhishwe izobe isikhuliswa kusetshenziswa ipulatifomu yokukhiqiza ye-Grit Bio i-StemTe...Funda kabanzi»
-
Amaseli e-TAEST16001 angamaseli e-T akhiwe ngofuzo aveza ubudlelwano obuphezulu be-NY-ESO-1-specific T-cell receptor (TCR) ehlose i-NY-ESO-1 (evezwa ezinhlakeni eziningi) i-positive soft tissue sarcoma (STS) kumongo we-HLA-A*02:01. Ucwaningo lwesigaba sokuqala ezigulini ezine-S ethuthukile...Funda kabanzi»
-
Disemba 04, 2024, i-New Drug Application (NDA) yokuhlanganiswa kwe-TYVYT® (isijovo se-sintilimab) kanye ne-ELUNATE® (fruquintinib) inikezwe imvume enemibandela eShayina yokwelapha iziguli ezinomdlavuza we-endometrial othuthukisiwe ezinezimila ze-Mismatch Repair proficient (pMMR) ezine ...Funda kabanzi»
-
I-GC203 iyindlela entsha yokwelapha i-TIL engaguquki izakhi zofuzo ye-vector ethuthukiswe kusetshenziswa ipulatifomu yokukhulisa amaseli ye-DeepTIL® ye-Juncell Therapeutics kanye nepulatifomu yokuguqula izakhi zofuzo ye-NovaGMP®. I-DeepTIL® ivumela ama-TIL ukuthi abe namandla ngokwanele kangangokuthi akukho nhlanganisela ye-IL-2 ezodingeka ngemuva kokufakwa,...Funda kabanzi»
-
I-Glioblastoma Multiforme (GBM) ingenye yezinhlobo zomdlavuza ezibulala kakhulu, futhi cishe zonke iziguli ziphinde zibhekane nokwanda kwesifo ngokwezinga lamanje lokunakekelwa kwe-GBM esanda kutholakala. I-GBM ephindaphindayo (rGBM) ibonisa ukusinda okuphakathi okungaphansi kwezinyanga ezingu-8 ngezinketho zokwelapha ezilinganiselwe. I-TX103 iyi-CAR-T ce...Funda kabanzi»
- Idatha Yomtholampilo Yakamuva ye-RD13-02 Yokwelapha Iziguli Ezine-R/R T-ALL/LBL Ekubonisweni Komlomo
I-RD13-02 iwumkhiqizo wamaseli e-CAR-T ojwayelekile ohlose i-CD7 etholakala kubanikeli abanempilo, futhi ihloselwe ukwelapha i-T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL) ephinde yatholakala noma engaphikiswa. Ishintshwe ngofuzo ukuze igweme i-fratricide, isifo se-graft-versus-host (GvHD), kanye ne-host-versus-...Funda kabanzi»